Essilor · FDA Authorized Myopia Control

Stellest.

The first FDA-authorized prescription lens proven to slow myopia progression in children — by an average of 71% over two years.*

Book a pediatric myopia consult Our myopia program
The lens

An eyeglass lens designed to slow nearsightedness.

Myopia, often called nearsightedness, is predicted to affect 50% of the world’s population by 2050. The younger a child becomes myopic, the faster it tends to progress — raising lifetime risk of glaucoma, cataracts, and retinal detachment. Stellest is the first prescription eyeglass lens FDA-authorized to do something about it.

Best for: Kids ages 6–12 · Newly myopic patients · Families looking to slow nearsightedness progression

Worth a look

Other lens technologies.